776 - 800 of 8587 Results
Title
Year
-
RESTRICTEDTitle: The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00587Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00587/pdfCitation Count: 32
-
RESTRICTEDTitle: Guilt-by-Association – Functional Insights Gained From Studying the LRRK2 InteractomeJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00485Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00485/pdfCitation Count: 10
-
RESTRICTEDTitle: Leucine Rich Repeat Kinase 2 and Innate ImmunityJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00193Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00193/pdfCitation Count: 37
- Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes2020RESTRICTEDTitle: Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 4Start Page: 319End Page: 331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1737017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174089Citation Count: 27
-
RESTRICTEDTitle: Pathways towards an effective immunotherapy for Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 11Issue #: 12Start Page: 1703End Page: 1715Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1586/ern.11.163Best OA location URL: https://europepmc.org/articles/pmc3263336?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’sJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00443Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00443/pdfCitation Count: 50
-
RESTRICTEDTitle: Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and InflammationJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00376Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00376/pdfCitation Count: 48
-
RESTRICTEDTitle: Deep brain stimulation for the treatment of uncommon tremor syndromesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 16Issue #: 8Start Page: 983End Page: 997Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2016.1194756Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2016.1194756?needAccess=trueCitation Count: 40
- Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences2016RESTRICTEDTitle: Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciencesJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 19Issue #: 2Start Page: 286End Page: 302Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bib/bbw114Best OA location URL: https://academic.oup.com/bib/article-pdf/19/2/286/25524262/bbw114.pdfCitation Count: 515
- How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature2023RESTRICTEDTitle: How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literatureJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100174End Page: 100174Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100174Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100174Citation Count: 2
-
RESTRICTEDTitle: Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal gangliaJournal Name: British Journal of PharmacologyPublisher: WileyVol: 173Issue #: 13Start Page: 2069End Page: 2079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/bph.13215Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.13215Citation Count: 58
-
RESTRICTEDTitle: Vesicle trafficking and lipid metabolism in synucleinopathyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 491End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02177-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772270Citation Count: 28
- P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease2022RESTRICTEDTitle: P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 5Start Page: 1881End Page: 1894Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02097-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02097-2.pdfCitation Count: 5
-
RESTRICTEDTitle: Autophagy and the hallmarks of agingJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 72Issue #:Start Page: 101468End Page: 101468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.arr.2021.101468Best OA location URL: http://manuscript.elsevier.com/S1568163721002154/pdf/S1568163721002154.pdfCitation Count: 115
- Transcriptional landscape of human microglia implicates age, sex, and APOE ‐related immunometabolic pathway perturbations2022RESTRICTEDTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE ‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 25
-
RESTRICTEDTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 63
-
RESTRICTEDTitle: Endoplasmic reticulum proteostasis impairment in agingJournal Name: Aging CellPublisher: WileyVol: 16Issue #: 4Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.12599Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.12599Citation Count: 166
- Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery2009RESTRICTEDTitle: Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug DiscoveryJournal Name: The AAPS JournalPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 167End Page: 177Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1208/s12248-009-9090-7Best OA location URL: https://europepmc.org/articles/pmc2664890?pdf=renderCitation Count: 148
-
RESTRICTEDTitle: Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 6Start Page: 847End Page: 847Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00110Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00110Citation Count: 0
- Physiological, pathological, and engineered cell identity reprogramming in the central nervous system2016RESTRICTEDTitle: Physiological, pathological, and engineered cell identity reprogramming in the central nervous systemJournal Name: WIREs Developmental BiologyPublisher: WileyVol: 5Issue #: 4Start Page: 499End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/wdev.234Best OA location URL: https://europepmc.org/articles/pmc4911333?pdf=renderCitation Count: 7
-
RESTRICTEDTitle: Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safetyJournal Name: WIREs Nanomedicine and NanobiotechnologyPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/wnan.1444Best OA location URL: https://europepmc.org/articles/pmc5422143?pdf=renderCitation Count: 110
- Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders2011RESTRICTEDTitle: Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 873End Page: 882Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2011.06.001Best OA location URL: https://europepmc.org/articles/pmc3264546?pdf=renderCitation Count: 78
-
RESTRICTEDTitle: S-Nitrosylation in neurogenesis and neuronal developmentJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1850Issue #: 8Start Page: 1588End Page: 1593Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2014.12.013Best OA location URL: https://doi.org/10.1016/j.bbagen.2014.12.013Citation Count: 46
-
RESTRICTEDTitle: Novel Methods and Technologies for 21st-Century Clinical TrialsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 5Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.4524Best OA location URL: https://europepmc.org/articles/pmc4708881?pdf=renderCitation Count: 92
-
RESTRICTEDTitle: Use of ibuprofen and risk of Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 10Start Page: 863End Page: 869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820f2d79Best OA location URL: https://europepmc.org/articles/pmc3059148?pdf=renderCitation Count: 284